EFFECTOR Therapeutics (EFTR) Competitor Comparison
We are evaluating the key criteria listed to compare EFFECTOR Therapeutics (EFTR) against its competitors in the Biotechnology industry.
Market Capitalization
300 / 368Gross Profits
171 / 278Total Revenue
246 / 300EBITDA
116 / 337Free Cashflow
130 / 352Quick Ratio
337 / 357Earnings per Share
339 / 359Dividend yield
0 / 6Total Cash
302 / 358Performance 3 years
297 / 368Performance 5 years
279 / 368Performance 10 years
249 / 368Linearity 3 years
227 / 368Linearity 5 years
219 / 368Linearity 10 years
189 / 368Total Rank
315 / 368Dividend Rank
115 / 368Valuation Rank
320 / 368Piotroski Rank
227 / 368Muliplier Rank
336 / 368Performance 5 years - EFTR ranking 279 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.